Detalhe da pesquisa
1.
Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics.
Clin Infect Dis
; 73(9): e3288-e3295, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32887983
2.
Exercise retards hepatocarcinogenesis in obese mice independently of weight control.
J Hepatol
; 73(1): 140-148, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32302728
3.
Activation of brown adipose tissue enhances the efficacy of caloric restriction for treatment of nonalcoholic steatohepatitis.
Lab Invest
; 99(1): 4-16, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30258096
4.
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis.
Hepatology
; 67(5): 1754-1767, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28833331
5.
Long-Term Fate of Human Fetal Liver Progenitor Cells Transplanted in Injured Mouse Livers.
Stem Cells
; 36(1): 103-113, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28960647
6.
Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: Diagnostic and management implications.
J Gastroenterol Hepatol
; 34(2): 425-435, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29992621
7.
Mouse models of non-alcoholic steatohepatitis: A reflection on recent literature.
J Gastroenterol Hepatol
; 33(7): 1312-1320, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29424123
8.
Deriving and testing of dysplastic murine hepatocytes: A new platform in liver cancer research.
Exp Cell Res
; 356(1): 48-56, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28408319
9.
Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease.
Adv Exp Med Biol
; 1061: 19-44, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29956204
10.
Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH.
J Lipid Res
; 58(6): 1067-1079, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28404639
11.
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
J Hepatol
; 66(5): 1037-1046, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28167322
12.
Defective adaptive thermogenesis contributes to metabolic syndrome and liver steatosis in obese mice.
Clin Sci (Lond)
; 131(4): 285-296, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27803297
13.
TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival.
Clin Sci (Lond)
; 131(16): 2145-2159, 2017 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28687713
14.
Non-alcoholic fatty liver disease: Not time for an obituary just yet!
J Hepatol
; 74(4): 972-974, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33340575
15.
Testosterone regulation of cyclin E kinase: A key factor in determining gender differences in hepatocarcinogenesis.
J Gastroenterol Hepatol
; 31(6): 1210-9, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26574916
16.
Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH.
J Lipid Res
; 56(2): 277-85, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25520429
17.
Acute atorvastatin is hepatoprotective against ischaemia-reperfusion injury in mice by modulating eNOS and microparticle formation.
Liver Int
; 35(9): 2174-86, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25786512
18.
Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent.
J Hepatol
; 61(6): 1376-84, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25064435
19.
CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis.
J Hepatol
; 61(6): 1365-75, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25048951
20.
Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis.
Hepatology
; 57(1): 81-92, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22508243